RH Treatment in the Real World: AHA 2022 Highlights

Target Audience
This activity has been designed to address the educational needs of primary care providers, including internists, family physicians, clinical pharmacists, nurse practitioners, and PAs, as well as nephrologists, cardiologists, endocrinologists, obesity specialists, gerontologists, and other clinicians who are involved or interested in the management of patients with resistant hypertension (RH).

Program Overview
Blood pressure control rates have been steadily declining in the United States. Join hypertension experts George Bakris, MD and Suzanne Oparil, MD for highlights of related RH data presented at the American Heart Association 2022 Scientific Sessions, including their takes on possible causes and interventions to combat this alarming trend.

Learning Objective
Upon completion of this activity, participants should be better able to:

Identify challenges associated with RH treatment in the real world